Covid-19: Novavax applies to Medsafe for vaccine use in New Zealand

A Stuff article.

Biotechnology company Novavax has filed for provisional approval to use its Covid-19 vaccine in New Zealand.

The application is now before drug safety regulator Medsafe, the company announced in a statement.

It is the first application related to a protein-based Covid-19 vaccine to reach Medsafe.

Read more.